Jonathan Feldschuh - 06 Dec 2024 Form 4 Insider Report for DAXOR CORP (DXR)

Role
Chief Scientific Officer, Director
Signature
/s/ Jonathan Feldschuh
Issuer symbol
DXR
Transactions as of
06 Dec 2024
Transactions value $
$0
Form type
4
Filing time
10 Dec 2024, 18:21:14 UTC
Previous filing
13 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXR Daxor Common Stock Purchase $0 +32,000 +819% $0 35,908 06 Dec 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 32,000 shares granted vest on December 6, 2024.